Clinical Convergence®: Approaching Chronic Urticaria from the Patient Perspective

Proprietary Educational Format:

Activity Overview

Although chronic urticaria (CU) occurs in the population at low frequency, its impact on patients’ lives, including work productivity and social interactivity, is significant. The availability of evidence-based treatment guidelines has done little to curb the confusion surrounding appropriate diagnosis, treatment, and management of symptoms in patients with CU. Consequently, patients with CU continue to experience a lowered quality-of-life associated with the disease itself, as well as the side effects resulting from treatment.

CE Credit Expired
Expires: March 6, 2020

Target Audience

This activity is designed to meet the educational needs of S-based allergy/immunology and dermatology clinicians.

Learning Objectives

Upon successful completion of this education activity, participants should be better able to:

  • Recognize physical exam findings and symptomatology suggestive of chronic urticaria (CU) and appropriately apply evidence-based practices regarding diagnostic testing and laboratory workup
  • Utilize a guideline-driven approach to treatment intensification for safe and effective management of patients with CU in need of second- and third-line treatment options, while taking into account quality of life issues

Activity Faculty

Michael E. Manning, MD, FAAAAI, FACAAI

President/Medical Director
Medical Research of Arizona
Allergy, Asthma and Immunology Associates, Ltd.
Scottsdale, AZ

Anne Marie Ditto, MD

Associate Professor, Medicine
Division of Allergy-Immunology
Northwestern University
Feinberg School of Medicine
Chicago, IL